Clinical Trials Logo

Skin Aging clinical trials

View clinical trials related to Skin Aging.

Filter by:

NCT ID: NCT02104960 Completed - Skin Aging Clinical Trials

Study of Skin Parameters in the PROOF Cohort

PEAU PROOF
Start date: March 2013
Phase: N/A
Study type: Observational

This study aims to evaluate skin aging of an homogeneous population of 77 years old patient selected among the PROOF cohort who has been continuously investigated by cardiological examination. Skin aging will be explored by macroscopic and microscopic evaluation. In particular, skin aging will be measured by an index of clinical aging (SCINEXA) and other complementary measures such as facial photos, standard and High Definition dermoscopy, elastography, sebumetry, in vivo and ex vivo confocal microscopy, and classical histological examinations.

NCT ID: NCT02063971 Active, not recruiting - Skin Aging Clinical Trials

Tolerance and Efficacy Evaluation of 3 Face Creams

FILLER
Start date: December 2013
Phase: N/A
Study type: Interventional

The study will evaluate the tolerance and the efficacy on skin comfort of F#1048-082 soothing cream used just after injection procedure and also the tolerance and the efficacy of the F#841-020 anti-age cream on aging parameters compared to baseline and to the F#1374-002 placebo cream (comparison within subjects - half face method) to identify additional benefits delivered by the product compared to a cosmetic procedure.

NCT ID: NCT02003833 Completed - Skin Aging Clinical Trials

Poly-L-lactic Acid for Skin Quality

Start date: September 2013
Phase: Phase 4
Study type: Interventional

Anecdotal evidence suggests that patients' skin quality may improve as a result of poly-L-lactic acid injection. While this is not the primary goal of such treatments it is often seen and described as so called "Sculptra glow". The aim of this study is to evaluate the effect of repeated subcutaneous injections of poly-L-lactic acid (Sculptra Aesthetic) on skin quality. Participating subjects will be part of the study for about 15 months. There will be an initial treatment period of up to 12 weeks, followed by a 12-month follow-up period. There will be a total of 7 scheduled visits. This study is a double-blind, randomized study. "Double-blind" means that neither the subjects nor the study doctor will know who is receiving Sculptra Aesthetic or placebo. "Randomized" means that the group subjects will be placed in is decided by chance, similar to drawing numbers out of a hat or flipping a coin. Subjects will have a 1 out of 2 chance of receiving the active study drug. After the completion of the study, if subjects are assigned to the control (placebo) group they will receive free injections with Sculptra Aesthetic same as the treatment group.

NCT ID: NCT01981980 Completed - Skin Aging Clinical Trials

Comparison of the Effects of Carboxytherapy and Radiofrequency on Skin Rejuvenation

Start date: October 2009
Phase: N/A
Study type: Interventional

Carboxytherapy (CA) refers to the cutaneous and subcutaneous administration of carbon dioxide gas [CO2] for therapeutic purposes. Radiofrequency (RF) is a method that uses electric current to generate heat into the layers of the skin and the subcutaneous tissue. Both techniques are indicated to the treatment of skin laxity. The aim of this study was to compare the effects of CA an RF on human skin. Methods: Eight patients who underwent abdominoplasty surgery received a single procedure of both treatments. Untreated skin was used as control. In an area of 49 cm2 (7 x 7 cm) in the infra-umbilical region CA was performed on the right and RF on the left side. Sample collection period ranged from zero to 120 days. CA was administered at a velocity of 40 ml/min, and the total quantity of CO2 infused was approximately 20ml. RF was carried out in a temperature higher than 40ºC on the epidermis for 5 minutes after reaching this temperature.

NCT ID: NCT01940991 Completed - Skin Aging Clinical Trials

Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Start date: August 2013
Phase: Phase 2
Study type: Interventional

This study will confirm the efficacy and safety of a single topical administration of botulinum toxin type A compared to placebo control for the treatment of moderate to severe crow's feet lines

NCT ID: NCT01818076 Terminated - Skin Aging Clinical Trials

Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Start date: February 2013
Phase: Phase 3
Study type: Interventional

This study will evaluate the long-term safety of botulinum toxin type A for the treatment of moderate to severe crow's feet lines after repeat application.

NCT ID: NCT01791920 Completed - Skin Aging Clinical Trials

To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines

Start date: August 2011
Phase: Phase 3
Study type: Interventional

To compare the safety and efficacy of Botulax® with Botox® in the improvement of moderate to severe glabellar lines.

NCT ID: NCT01783496 Completed - Skin Aging Clinical Trials

Thermage CPT for Treatment of Facial and Neck Laxity

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study to evaluate treatment with the Thermage CPT system for facial and neck laxity.

NCT ID: NCT01776606 Completed - Skin Aging Clinical Trials

Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

RADIANT
Start date: December 2012
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of botulinum toxin type A compared to placebo control for the treatment of moderate to severe crow's feet lines.

NCT ID: NCT01583478 Recruiting - Skin Aging Clinical Trials

Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids

Start date: September 2014
Phase: Phase 4
Study type: Interventional

The objective of the study is to compare the efficacy and duration of escalating doses of IncobotulinumtoxinA (Xeomin®) in the treatment of glabellar rhytids (frown lines between the eyes). Fifteen subjects will be enrolled in the study; specifically 60 male or female patients 18 years of age or older with moderate to severe glabellar rhytids at maximum contracture. Each patient will be randomized to receive one of 5 doses of Xeomin®, in a one-time dose to the treatment area. The efficacy endpoints will be determined by investigator and subject live assessment of the glabellar rhytids at rest and maximum contraction at each visit (every other day for 6 days post-injection, every month for 9 months following) using a validated 4 point photographic scale (minimal wrinkles [0], mild wrinkles [1], moderate wrinkles [2], or severe wrinkles [3]) used in previous studies. A written description of each photograph will be included to help standardize the application of the Photographic Scale.